Vivos Therapeutics Inc
(NAS:VVOS)
$
3.1
0.25 (8.8%)
Market Cap: 14.77 Mil
Enterprise Value: 8.39 Mil
PE Ratio: 0
PB Ratio: 1.52
GF Score: 65/100 Vivos Therapeutics Inc at Benzinga Global Small Cap Conference (Virtual) Transcript
Oct 27, 2021 / 04:15PM GMT
Release Date Price:
$88.25
(-1.67%)
Spencer Israel
Benzinga - Moderator
I see our next speaker here in the chat, let's see if we can bring them on. Vivos Therapeutics is the company, VVOS is the ticker. Kirk Huntsman is the Co-Founder, Chairman, and the CEO, and there he is. How are we doing today, sir?
Kirk Huntsman
Vivos Therapeutics, Inc. - CEO, Chairman, Co-Founder
Good, Spencer. How are you?
Spencer Israel
Benzinga - Moderator
Doing fantastic, fantastic. Thank you for asking. Let me get your slides up here. I see them.
Kirk Huntsman
Vivos Therapeutics, Inc. - CEO, Chairman, Co-Founder
All right.
Spencer Israel
Benzinga - Moderator
There they are. And all right. Very excited here about Vivos, tell us all about it.
Kirk Huntsman
Vivos Therapeutics, Inc. - CEO, Chairman, Co-Founder
All right. Thank you very much. Great to be back at Benzinga and appreciate the opportunity.
So Vivos is a medical
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot